Ratios of One-Carbon Metabolites Are Functional Markers of B-Vitamin Status in a Norwegian Coronary Angiography Screening Cohort.

Background: Functional (metabolic) markers of B-vitamin status, including plasma total homocysteine (tHcy) for folate and plasma methylmalonic acid (MMA) for vitamin B-12, suffer from moderate sensitivity and poor specificity. Ratios of metabolites belonging to the same pathway may have better performance characteristics.Objective: We evaluated the ratios of tHcy to total cysteine (tCys; Hcy:Cys), tHcy to creatinine (Hcy:Cre), and tHcy to tCys to creatinine (Hcy:Cys:Cre) as functional markers of B-vitamin status represented by a summary score composed of folate, cobalamin, betaine, pyridoxal 5'-phosphate (PLP), and riboflavin concentrations measured in plasma.Methods: Cross-sectional data were obtained from a cohort of patients with stable angina pectoris (2994 men and 1167 women) aged 21-88 y. The relative contribution of the B-vitamin score, age, sex, smoking, body mass index, and markers of renal function and inflammation to the variance of the functional B-vitamin markers was calculated by using multiple linear regression.Results: Compared with tHcy alone, Hcy:Cys, Hcy:Cre, and Hcy:Cys:Cre all showed improved sensitivity and specificity for detecting plasma B-vitamin status. Improvements in overall performance ranged from 4-fold for Hcy:Cys to ∼8-fold for Hcy:Cys:Cre and were particularly strong in subjects with the common 5,10-methylenetetrahydrofolate reductase (MTHFR) 677CC genotype.Conclusions: Ratios of tHcy to tCys and/or creatinine showed a severalfold improvement over tHcy alone as functional markers of B-vitamin status in Norwegian coronary angiography screenees. The biological rationale for these ratios is discussed in terms of known properties of enzymes involved in the catabolism of homocysteine and synthesis of creatine and creatinine.

[1]  G. S. Sharma,et al.  Homocystinuria: Therapeutic approach. , 2016, Clinica chimica acta; international journal of clinical chemistry.

[2]  Michael Reed,et al.  Mathematical analysis of the regulation of competing methyltransferases , 2015, BMC Systems Biology.

[3]  K. Bønaa,et al.  Elevated plasma dimethylglycine is a risk marker of mortality in patients with coronary heart disease , 2015, European journal of preventive cardiology.

[4]  S. Eussen,et al.  Substrate product ratios of enzymes in the kynurenine pathway measured in plasma as indicators of functional vitamin B-6 status. , 2013, The American journal of clinical nutrition.

[5]  P. Ueland,et al.  Plasma Dimethylglycine and Risk of Incident Acute Myocardial Infarction in Patients With Stable Angina Pectoris , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[6]  P. Ueland,et al.  High-throughput, low-volume, multianalyte quantification of plasma metabolites related to one-carbon metabolism using HPLC-MS/MS , 2013, Analytical and Bioanalytical Chemistry.

[7]  S. Eussen,et al.  Kinetic modeling of storage effects on biomarkers related to B vitamin status and one-carbon metabolism. , 2012, Clinical chemistry.

[8]  Y. Lamers.  Indicators and methods for folate, vitamin B-12, and vitamin B-6 status assessment in humans , 2011, Current opinion in clinical nutrition and metabolic care.

[9]  P. Ueland,et al.  Low plasma vitamin B-6 status affects metabolism through the kynurenine pathway in cardiovascular patients with systemic inflammation. , 2011, The Journal of nutrition.

[10]  O. Tutarel,et al.  Symmetrical Dimethylarginine Outperforms CKD-EPI and MDRD-Derived eGFR for the Assessment of Renal Function in Patients with Adult Congenital Heart Disease , 2010, Kidney and Blood Pressure Research.

[11]  H. McNulty,et al.  Studies of biomarker responses to intervention with riboflavin: a systematic review. , 2009, The American journal of clinical nutrition.

[12]  P. Ueland,et al.  Quantitative profiling of biomarkers related to B-vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography/tandem mass spectrometry. , 2009, Rapid communications in mass spectrometry : RCM.

[13]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[14]  L. Allen,et al.  Provision of multiple rather than two or fewer micronutrients more effectively improves growth and other outcomes in micronutrient-deficient children and adults. , 2009, The Journal of nutrition.

[15]  S. Vollset,et al.  Angiography : A Randomized Controlled Trial CoronaryWith Homocysteine-Lowering B Vitamins After Mortality and Cardiovascular Events in Patients Treated , 2008 .

[16]  S. Vollset,et al.  The methylenetetrahydrofolate reductase 677C-->T polymorphism as a modulator of a B vitamin network with major effects on homocysteine metabolism. , 2007, American journal of human genetics.

[17]  J. Cooke,et al.  Symmetric dimethylarginine (SDMA) as endogenous marker of renal function--a meta-analysis. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  Ulrike Groemping,et al.  Relative Importance for Linear Regression in R: The Package relaimpo , 2006 .

[19]  J. Selhub,et al.  The many facets of hyperhomocysteinemia: studies from the Framingham cohorts. , 2006, The Journal of nutrition.

[20]  P. Ueland,et al.  Automated assay for the determination of methylmalonic acid, total homocysteine, and related amino acids in human serum or plasma by means of methylchloroformate derivatization and gas chromatography-mass spectrometry. , 2005, Clinical chemistry.

[21]  P. Ueland,et al.  Betaine: a key modulator of one-carbon metabolism and homocysteine status , 2005, Clinical chemistry and laboratory medicine.

[22]  S. Vollset,et al.  Betaine and Folate Status as Cooperative Determinants of Plasma Homocysteine in Humans , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[23]  M. Landray,et al.  Homocysteine, renal function, and risk of cardiovascular disease. , 2003, Kidney international. Supplement.

[24]  P. Wilson,et al.  Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. , 2001, The American journal of clinical nutrition.

[25]  M. Wyss,et al.  Creatine and creatinine metabolism. , 2000, Physiological reviews.

[26]  S. Vollset,et al.  Total homocysteine and cardiovascular disease , 1999, Journal of internal medicine.

[27]  P. Reitsma,et al.  The effect of a common methylenetetrahydrofolate reductase mutation on levels of homocysteine, folate, vitamin B12 and on the risk of premature atherosclerosis. , 1998, Atherosclerosis.

[28]  K. Pietrzik,et al.  Vitamins B12, B6 and folate as determinants of homocysteine concentration in the healthy population , 1998, European Journal of Pediatrics.

[29]  S. O'broin,et al.  Microbiological assay on microtitre plates of folate in serum and red cells. , 1992, Journal of clinical pathology.

[30]  B. Kelleher,et al.  Microbiological assay for vitamin B12 performed in 96-well microtitre plates. , 1991, Journal of clinical pathology.

[31]  H. Tunstall-Pedoe,et al.  Comparison of tests used to distinguish smokers from nonsmokers. , 1987, American journal of public health.

[32]  E. Podell,et al.  Quantitation of methylmalonic acid and other dicarboxylic acids in normal serum and urine using capillary gas chromatography-mass spectrometry. , 1985, Analytical biochemistry.

[33]  R. Brown,et al.  Effects of vitamin B-6 deficiency and tryptophan loading on urinary excretion of tryptophan metabolites in mammals. , 1977, The Journal of nutrition.

[34]  O. Wiss,et al.  The assessment of riboflavin status , 1973, Proceedings of the Nutrition Society.

[35]  W. N. Pearson.  Blood and urinary vitamin levels as potential indices of body stores. , 1967, The American journal of clinical nutrition.

[36]  H. Sauberlich,et al.  BLOOD CELL TRANSAMINASE ACTIVITY IN HUMAN VITAMIN B6 DEFICIENCY. , 1964, The American journal of clinical nutrition.

[37]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .